Could a common diabetes pill slow down Alzheimer's?
NCT ID NCT07200622
Summary
This study is testing if a pill called oral semaglutide, currently used for diabetes, is safe and might help slow Alzheimer's disease. It will involve 60 people with mild Alzheimer's to see if the drug protects the brain's communication points. The main goal is to check safety, while a secondary goal uses brain scans to see if the drug helps preserve brain connections over one year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.